Khiron Expands Product Offering in UK and Increases Patient Access

Article feature image

  • Following successful medical cannabis launch in Germany, Khiron 1/14, a high CBD flower is expected to be available in Q2/21 for UK patients
  • Khiron plans to introduce additional cannabis-based medical products with its registered strains, recently exported from Colombia to Europe
  • Supply chain improvements will increase availability of medical cannabis for patients in the United Kingdom

TORONTO, April 7, 2021 /PRNewswire/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX:…

Click here to view the original article.

S&P/ASX 200 
7,065.60  2.10  0.03%  
ALL ORDINARIES 
7,328.00  2.20  0.03%  
Dow Jones Industrial Average 
34,200.67  164.67  0.48%  
S&P 500 
4,185.47  15.05  0.36%  
NASDAQ Composite 
14,052.34  13.54  0.10%  
NYSE COMPOSITE (DJ) 
16,186.30  69.50  0.43%  
FTSE 100 
7,031.01  11.48  0.16%  
DAX PERFORMANCE-INDEX 
15,468.86  9.11  0.06%  
Nikkei 225 
29,685.37  2.00  0.01%  
HANG SENG INDEX 
29,109.24  139.53  0.48%